Wirelessly Enabled Injection Devices to 2022
|出版商||Greystone Research Associates||商品編碼||428084|
|無線支援的注射設備 2022年 Wirelessly Enabled Injection Devices to 2022|
|出版日期: 2017年01月30日||內容資訊: 英文||
本報告提供加入無線連接技術的藥物注射設備的市場相關調查，其結構與提供給患者、HCP (醫護人員) 的新功能，支援無線的注射器帶給患者的優點，無線支援設備現在聚焦的治療領域，支撐無線支援注射設備成長的企業，及無線支援注射設備市場成長的主要促進要素等相關詳細分析。
For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient's quality-of-life. Wirelessly enabled devices - drug injection devices that are designed to address the patient adherence issue by reminding and recording data about patient dosing activity and making it available to HCPs - are gaining interest among industry and managed care participants. Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.
A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.
‘Much of the activity surrounding connected drug injection devices is focused on chronic diseases - conditions where the ability of caregivers to access data on patient self-administration activities, patient reported outcomes, and feedback on the user experience can yield significant benefits in patient Quality of Life.'